Merus NV (MRUS)
48.36
+0.86
(+1.81%)
USD |
NASDAQ |
May 03, 16:00
48.50
+0.14
(+0.29%)
After-Hours: 20:00
Merus Revenue (TTM): 43.95M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.95M |
| September 30, 2023 | 45.67M |
| June 30, 2023 | 41.22M |
| March 31, 2023 | 43.43M |
| December 31, 2022 | 41.59M |
| September 30, 2022 | 45.63M |
| June 30, 2022 | 52.72M |
| March 31, 2022 | 52.41M |
| December 31, 2021 | 49.11M |
| September 30, 2021 | 43.41M |
| June 30, 2021 | 38.32M |
| March 31, 2021 | 31.99M |
| December 31, 2020 | 29.94M |
| September 30, 2020 | 28.72M |
| June 30, 2020 | 28.30M |
| March 31, 2020 | 28.60M |
| December 31, 2019 | 31.13M |
| September 30, 2019 | 35.25M |
| Date | Value |
|---|---|
| June 30, 2019 | 34.64M |
| March 31, 2019 | 35.72M |
| December 31, 2018 | 39.04M |
| September 30, 2018 | 34.39M |
| June 30, 2018 | 33.53M |
| March 31, 2018 | 32.33M |
| December 31, 2017 | 24.29M |
| September 30, 2017 | 16.93M |
| June 30, 2017 | 11.24M |
| March 31, 2017 | 5.225M |
| December 31, 2016 | 1.180M |
| September 30, 2016 | 1.299M |
| June 30, 2016 | 0.4072M |
| March 31, 2016 | 1.434M |
| December 31, 2015 | 1.431M |
| September 30, 2015 | 1.888M |
| June 30, 2015 | 2.176M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
28.30M
Minimum
Jun 2020
52.72M
Maximum
Jun 2022
39.27M
Average
41.22M
Median
Jun 2023
Revenue (TTM) Benchmarks
| argenx SE | 1.226B |
| uniQure NV | 15.84M |
| ProQR Therapeutics NV | 7.046M |
| Pharming Group | 245.32M |
| Pharvaris NV | -- |